Our website is set to allow the use of cookies. For more information click here. If you are happy with cookies please click 'Proceed' or simply continue browsing.

Select a localised edition of our website

Matthew Royle, Tim Worden and Paul England of Taylor Wessing discuss the issues raised by Brexit for the authorisation of medicinal products and medical devices, and how the available exclusivity rights for these products may be affected.

${expertFirstname} ${expertSurname}

${expertJobtitle} | ${expertOffice}

{{if expertProfileimage!="99999999"}}
{{if expertMobile!=""}}

Next Event